Stoneridge Investment Partners’s Eastman Chemical EMN Stock Holding History

Stoneridge Investment Partners’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,087	Closed	-$699K	–	138
2025 Q3	$699K	Buy	+11,087	New	+$774K	0.48%	61
2015 Q2	–	Sell	-19,884	Closed	-$1.38M	–	282
2015 Q1	$1.38M	Buy	19,884 +1,999	+11%	+$144K	0.16%	160
2014 Q4	$1.36M	Sell	17,885 -100	-0.6%	-$7.91K	0.18%	147
2014 Q3	$1.46M	Buy	+17,985	New	+$1.5M	0.22%	134
2013 Q4	–	Sell	-39,054	Closed	-$3.04M	–	212
2013 Q3	$3.04M	Buy	+39,054	New	+$3.01M	0.67%	52

Other funds holding EMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stoneridge Investment Partners's EMN Position: Q4 2025 in Review

Stoneridge Investment Partners sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 11,087 shares — an estimated $699K sold.

Stoneridge Investment Partners first reported a position in EMN in Q3 2013 and held it in 5 quarters. The position peaked at $3.04M in Q3 2013. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

Stoneridge Investment Partners reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
Stoneridge Investment Partners sold 11,087 Eastman Chemical shares in Q4 2025, an estimated $699K.
Stoneridge Investment Partners first reported a position in Eastman Chemical in Q3 2013 and held it in 5 quarters.
Stoneridge Investment Partners's Eastman Chemical position peaked at $3.04M in Q3 2013.
633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.